Nova Cannabis NVCAF stock analysis & why NVCAF stock goes higher

Sonnet BioTherapeutics secures US patent covering two drug candidates

The company’s FHAB platform aims to target tumour and lymphatic tissue, improving the efficacy and safety of immune-modulating biologic drugs. Credit: Alex_Traksel via Shutterstock. Sonnet

November 8, 2024

Intellia plots Phase 3 study and a 2026 FDA submission after CRISPR therapy cuts swelling attacks by 98%

Intellia Therapeutics has revealed that a single infusion of its experimental CRISPR therapy, called NTLA-2002, almost entirely eliminated swelling attacks in 10 people with hereditary

June 3, 2024

Global efforts to reduce infectious diseases must include older children and adolescents

Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this

July 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.